Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Melatonin 1mg/ml liquid receives licence, Colonis Pharma says

Melatonin 1mg/ml oral solution for jet-lag has been licensed for use in the UK, manufacturer Colonis Pharma has announced.

The product can be used by adults to “facilitate sleep onset” and improve “quality of sleep”, the manufacturer said.

“Prior to this launch, licensed liquid melatonin was unavailable. Instead, clinicians have prescribed a variety of unlicensed products,” Colonis said.

The strawberry-flavoured oral solution is lactose and sugar-free. It provides “maximal dose flexibility” and can be used by patients across a “wide age range”, Colonis said.

The NHS price for 150ml of melatonin 1mg/ml oral solution is £130.00.

Melatonin 1mg/ml oral solution is available from mainline wholesalers including AAH, Alliance Healthcare and Phoenix Healthcare. For more information, contact Colonis on 01892 739 403 or [email protected]

Do you have patients who struggle with sleep?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005959

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel